Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 Diabetes

NCT02235298 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT02235298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02235298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 Diabetes
Lead sponsor
University of Miami
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2015
Completion date
September 10, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes